Federal Actions and Selected Non-Federal Practices to Facilitate Diversity of Patients

Government Accountability Office (GAO): Federal Actions and Selected Non-Federal Practices to Facilitate Diversity of Patients The GAO released a report describing actions taken by federal agencies and non-federal cancer centers to facilitate enrollment of patients from diverse backgrounds in cancer clinical trials. The report found that the Departments of Health and Human Services [...]

2023-01-24T13:15:57-04:00December 19th, 2022|

Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials

JAMA Internal Medicine: Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials A study published in JAMA Internal Medicine found systemwide differences in representation for several key demographic groups in COVID-19 prevention and treatment trials in the U.S. In this systematic review, female participants were underrepresented in treatment trials, Asian and Black participants [...]

2023-01-24T13:08:31-04:00December 5th, 2022|
Go to Top